Alector - Stock Price History | ALEC

Historical daily share price chart and data for Alector since 2021 adjusted for splits. The latest closing stock price for Alector as of September 27, 2021 is 23.99.
  • The all-time high Alector stock closing price was 39.49 on July 07, 2021.
  • The Alector 52-week high stock price is 43.32, which is 80.6% above the current share price.
  • The Alector 52-week low stock price is 9.12, which is 62% below the current share price.
  • The average Alector stock price for the last 52 weeks is 19.24.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Alector Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 20.3552 16.5750 35.2800 9.4000 15.1300 -12.19%
2019 18.5147 18.0000 26.4200 14.1700 17.2300 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.940B $0.021B
Alector Inc. is a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. Its product portfolio includes AL001, AL101, Al002 and AL003 which are in clinical stage. Alector Inc. is headquartered in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29